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Background: High-cholesterol diet (HCD) increases the oxidative stress in different tissues leading to many
diseases. Rutin (RT) is a natural flavonoid (vitamin p), which possesses an antioxidant activity with protective
potential. The present study aimed to examine the potential effects of rutin on hypercholesterolemia-induced
hepatotoxicity in rat.
Methods: Male Wistar rats were divided into four groups: GI) control (Rat chow), GII) Rutin (0.2% in rat chow), GIII)
HCD (1% cholesterol and 0.5% cholic acid in rat chow) and GIV) rutin (0.2%) + HCD.
Results: Rutin in combination with HCD induced a significant protective effect against the hepatotoxicity by
reducing the plasma level of alanine transaminase (ALT), aspartate aminotransferase (AST), triglyceride (TG), total
cholesterol (TC), and low-density lipoprotein (LDL). The HCD (GII) showed a decrease in glutathione peroxidase (GPx),
glutathione reductase (GR) and increase in glutathione S transferase α (GSTα), sulfiredoxin-1(Srx1), glutamate-cysteine
ligase (GCL) and paraoxonase-1(PON-1) genes expression levels.
Conclusion: Treatment with rutin reversed all the altered genes induced by HCD nearly to the control levels. The
present study concluded that the HCD feedings altered the expression levels of some genes involved in the
oxidative stress pathway resulting in DNA damage and hepatotoxicity. Rutin have a hepatoprotective effect through
the mechanism of enhancing the antioxidant effect via amelioration of oxidative stress genes.
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Hypercholesterolemia is considered as one of the most
familiar metabolic disorders and it is closely associated
with obesity, diabetes mellitus, and several other meta-
bolic syndromes [1,2]. It can eventually lead to non-
alcoholic fatty liver disease (NAFLD) by depositing the
lipids and triglycerides in liver which is usually progress
to nonalcoholic steato-hepatitis (NASH), cirrhosis, liver
failure and hepatocellular carcinoma [3,4]. NAFLD is
characterized by destruction in liver n-6 and n-3 long-
chain polyunsaturated fatty acids [5,6]. A major factor
associated with these liver fatty acids depletion in obesity
is the development of prolonged oxidative stress, which* Correspondence: mohhafez_2000@yahoo.com
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reproduction in any medium, provided the ormay be compounded by defective desaturation activity
and dietary imbalance, promoting hepatic steatosis [6,7].
Earlier studies demonstrated that, even short exposure
to HCD is capable of inducing hypercholesterolemia and
is significantly associated with oxidative stress [8].
Obesity is increasing worldwide especially in places
with high dietary fat intake and is associated with lot of
complications including NAFLD [9]. NAFLD is a com-
mon disease with an estimated prevalence in unselected
population of developed nations around 20–30% [10].
From last three decades, Saudi Arabia has been under-
going massive developments. These developments are
causing drastic changes in lifestyles and dietary habitats,
like many other developed societies some of these
changes tremendously increasing physical disorders such
as obesity and NAFLD. The prevalence of overweight inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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than females (31.8%) [11] and recently Al-hamoudi et al.,
reported prevalence of NAFLD is around 17% in Saudi
population [12].
Accumulation of lipid in hepatocytes may cause a dys-
function in the synthesis of fatty acids. Transcription fac-
tors such as sterol-regulatory-element-binding protein-1c
(SREBP) and peroxisome proliferator-activated receptor
alpha (PPARs) promote hepatic fatty acid synthesis. Long
chain polyunsaturated fatty acids and acyl-CoAs, are meta-
bolic regulators of many transcription factors that motivate
the liver lipid metabolism. Fatty acids induce changes
in the activity of four transcription factor families:
PPARs, LXRs, hepatic nuclear factor 4, and SREBP [13,14].
Downregulation of gene expression by fatty acids would
be restricted to polyunsaturated fatty acids, but the
upregulation would be independent of the saturation
[15]. These Differences might involve differential me-
tabolism (oxidative pathways, kinetics etc.) and selective
transport of fatty acids to the nucleus. Polyunsaturated
fatty acids regulates the genes involved in fatty acid oxida-
tion such as PPARa target genes in which suppress SREBP-
1c activity, leading to a reduction in liver triacylglycerol
content [16]. The liver is a major source of newly syn-
thesized cholesterol. Cholesterol can be derived from
newly-absorbed cholesterol, peripheral tissues and chol-
esterol synthesized within liver. Cholesterol taken up by
the liver is in the form of cholesterol esters [17] which
can be either stored as esters or hydrolyzed to free
cholesterol [18].
Oxidative stress is highly correlated with a wide variety
of inflammatory, cancer, brain disorders, and metabolic
disease states, including obesity [19,20]. It is highly cor-
related with cumulative damage done by reactive oxygen
species (ROS) and reactive nitrogen species (RNS) inad-
equately neutralized by antioxidants mechanisms [21,22].
It has been shown that free radicals may adversely affect
cell survival through the oxidative damage of lipid, pro-
tein, and irreversible DNA modification [23,24]. Damage,
at the cellular level by oxidants, is attenuated by antioxi-
dant enzyme [25]. Furthermore oxidative damage is ag-
gravated by the decrease in antioxidant enzymes activities
which acts as a free radical scavengers in conditions associ-
ated with oxidative stress [26]. Superoxide dismutase is
one of the major enzymatic antioxidant mechanisms
against superoxide radical, prevents liver toxicity induced
by oxidative stress [27]. Catalase and GSHPx catalyze
dismutation of the superoxide anion (O2-) into hydrogen
peroxide (H2O2) which then converting H2O2 to water
thus providing protection against ROS [28]. The reduction
in activity of these enzymes may be caused by the increase
in free radical induced by HCD [29,30]. Paraoxonase
(PON1) is another antioxidant enzyme closely associ-
ated with high-density lipoproteins, which detoxifies lipidperoxides, and is widely distributed in many tissues, such
as liver [31]. Sulfiredoxin-1 enzyme, belongs to the family
of oxidoreductases, catalyzes reduction of cysteine sulfinic
acid to sulfenic acid in oxidized proteins and pro-
tects them from inactivation [32]. Glutamate–cysteine
ligase, composed of catalytic subunit (called GCLC) and
regulatory subunit (called GCLM), is important for GSH
biosynthesis in combating a variety of oxidative stress-
related complications, thereby activating the body’s own
protective response [33].
Flavonoids are polyphenolic compounds found in
plants and have an important role in detoxification
of free radicals [34]. Rutin, flavonoid glycosides, possesses
different protective effects such as hepatoprotective
against carbon tetrachloride (CCl4)-induced liver injuries
in rats, ischemia/reperfusion-associated hemodynamic
alteration through antioxidant activity [35-39]. It has
an inhibitory effect against membrane lipid peroxida-
tion and oxidative stress-mediated diseases [40]. In
order to find out the possible mechanisms mediating
the antioxidant effect of RT, the present study evaluate
its effect on gene expression of hepatic antioxidant en-




Twenty four young male Wistar albino rats six weeks
old with average body weight 80–100 gms, were
obtained from the Animal Care Center, College of
Pharmacy, King Saud University, Riyadh, Saudi Arabia.
The animals were acclimatized to laboratory condition
prior ten days to the experiment. They were fed on Purina
rat chow diet (Manufactured by Grain Silos &Flour Mills
Organization, Riyadh, Saudi Arabia) and water ad libitum
and were maintained under standard conditions of
temperature (22±1°C), humidity (50-55%) and a 12 h
light/dark cycles. All methods including euthanasia
procedure were conducted in accordance with Guide
for care and use of laboratory animals, institute for labora-
tory animal research, National Institute of Health (NIH
publication No. 80–23; 1996) and it has approved by Re-
search Ethics Committee of Excremental Animal Care
Center, College of Pharmacy, King Saud University, Riyadh
Saudi Arabia.
Dietary protocol and experimental groups
Dietary protocol
Experimental diets were prepared in pellet form by
adding 0.2% rutin (RT) [41] (power, sigma, USA) or 1%
cholesterol + 0.5% cholic acid (HCD) [42] or 0.2% RT +
1% cholesterol + 0.5% cholic acid (RT+HCD) in rat
chow powder. Rat chow was used as normal diets and
was prepared weekly and shade dried.
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The Animals were randomly divided into 4 groups of 6
rats in each as follows:
Group (I): Animals received rat chow only and
considered as control.
Group (II): Animals received rat chow + 0.2% rutin
(RT)
Group (III): Animals received rat chow + {1%
cholesterol +0.5% cholic acid }(HCD)
Group (IV): Animals received rat chow + 0.2% rutin
(RT) +{1% cholesterol +0.5% cholic acid }
(HCD).
The experimental diets were supplemented for 6 con-
secutive weeks. During whole experimental period, all
groups of animals were kept on free access to food and
water. At end of the experiment, animals were sacrificed
by decapitation and the trunk blood was collected in
heparinized tubes. Liver tissues were rapidly excised,
weighed and kept in −80°C until used. Plasma samples
were collected after centrifugation at 1252 g for 15 min
and kept in −20°C until used.
A-Bioassay measurments
I- Blood chemistry
Plasma levels of aspartate aminotransferase (ALT),
alanine aminotransferase (ALT), total cholesterol
(TC), triglyceride (TG), high density lipoprotein
(HDL), and low density lipoprotein (LDL) were
estimated by using commercially available diagnostic
kits (Human, Wiesbaden, Germany).
II- Estimation of Malondialdehyde (MDA) in liver
The method described by Ohkawa et al., [43] was
used to determine MDA concentration in liver.
Briefly, 200 mg of liver tissues were homogenized in
aqueous 0.15M KCl solution to give 10%
homogenate. One ml of homogenate was then
mixed with one ml of 10% trichloroacetic acid
(TCA) and centrifuged at 704 g for 15 min. one ml
of supernatant was suspended into one ml of 0.67%
2-thiobarbutaric acid. Sample tubes were then
placed into a boiling water bath for 15 min. Samples
were allowed to cool down at room temperature
followed by centrifugation at 704 g for 15 min. The
optical density of the clear pink supernatants was
measured at 532 nm by using spectrophotometer
(LKB-Pharmacia, Mark II, Ireland).
III-Estimation of (Glutathione) GSH levels in liver
The concentration of GSH was determined as
described by Sedlak and Lindsay [44]. Briefly, 200 gm
from liver tissue were dissected out and
homogenized in ice-cold 0.02Methylenediaminetetraacetic acid (EDTA). An
aliquots of 0.5ml of tissue homogenate was mixed
with 0.2M Tris buffer, pH 8.2 and 0.1 ml of 0.01 M
Ellman’s reagent, [5,5’-dithiobis-(2-nitr-benzoic acid)]
(DTNB). Each sample tube was centrifuged at 704 g at
room temperature for 15 min the absorbance of the
clear supernatant was measured using
spectrophotometer (LKB-Pharmacia, Mark II, Ireland)
at 412 nm.
IV-Assessment of plasma hydrogen peroxide
concentration
Plasma H2O2 concentration levels were measured by
BioVision assay kit (BioVision, CA, USA). The
principles based on the present of horse radish
peroxidase, the OxiRed probe react with H2O2 to
produce product with color that can be measure.
B- Assessment of gene expression level (GPx, GR, Srx1, GCL,
PON-1 and GST-α genes) by real time PCR in liver tissues
I- Total RNA extraction
Total RNA were extracted from liver using RNA
Mini kit (Bioline, Taunton,USA) according to the
manufacturer's protocol. The quantity and integrity
of total RNA were characterized using a UV
spectrophotometer (Nanodrop 8000 Thermo
Scientific, USA) and ethidium bromide stained
agarose gel. The isolated RNA has an A 260/280
ratio of 1.9–2.0.
II- cDNA synthesis and real time PCR methods
First-strand cDNA was synthesized from 1μg of total
RNA by reverse transcription with a SuperScript™
first-strand synthesis system kit (Invitrogen, CA,
USA), according to the manufacturer's instructions.
Real time PCR using ΔΔCT method was done
according to previous study [45]. We used GAPDH
gene as housekeeping gene. All primers used in this
study were synthesized in Metabion Company
(Metabion international AG, Germany) and listed in
Table 1.
Statistical analysis
Differences between obtained values (mean ± SEM, n = 6)
were carried out by one way analysis of variance followed
by the Tukey-Kramer multiple comparison. The differ-
ences were considered statistically significant at P<0.05.
Results
Liver enzymes, ALT and AST levels in plasma were used
as biochemical markers for the early acute hepatotoxicity.
Rats fed with HCD for 6 weeks had significant increase in
of AST and ALT levels (p<0.001) compared to control
group. Rutin supplementation alone showed no significant
changes in biochemical markers. However, administration
Table 1 Showing primers and probe used
Gene name Forward primer Reverse primer Probe
Glutathione peroxidase 5’-GGTGTTCCAGTGCGCAGAT-3’ 5’-AGGGCTTCTATATCGGGTTCGA-3’ FAM-CAGCAGGCGCTTTCGCACCA-TAMRA








Paraoxonase-1 5’-TGAGAGCTTCTATGCCACAAATG-3’ 5’-CCATGACAGGCCCAAGTACA-3’ FAM-TTTTGCTGACCCATACTTACGGTCCTGG-
TAMRA
Sulfiredoxin-1 5’-AATCCCCAACCCCTGACTTT-3’ 5’-TGAACTGACCAGTGGAGACACAGT-3’ FAM-ACAAGGTTTCTTCAGCCCCGGTGC-TAMRA
GAPDH 5'- TGGCCTCCAAGGAGTAAGAAAC -'3 5'- GGCCTCTCTCTTGCTCTCAGTATC -'3 FAM- CTGGACCACCCAGCCCAGCAA-TAMRA
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hepatic damage biomarker induced by HCD to normal
values (Table 2). Lipid parameters of HCD fed rats includ-
ing TG, TC and LDL levels were significantly increased in
plasma by 48%, 89% and 67% respectively and significantly
decreased the HDL levels by 17% compared to control
group. Rutin supplementation in combination with HCD,
significantly decreased TC and LDL levels compared to
HCD group. On the other hand there is no effect on TG,
TC, HDL and LHL was observed on the supplementation
of RT alone (Table 2).
The effect of HCD, rutin and their combination on the
oxidative stress biomarkers and indices of lipid peroxida-
tion, MDA, H2O2 and GSH were shown in Table 3. The
HCD feeding was resulted significant increase in liver
MDA by 23 % and in plasma H2O2 by 354 %, and de-
crease in hepatic GSH level by 17% compared to the
control group. Rutin administration in combination with
HCD resulted in a significant decrease in the levels of
MDA and H2O2 and increase the hepatic level of GSH
compared to HCD group.
The present results showed an insignificant decrease
by 23% in the expression of GPX gene and significant
decrease by 65% in GR genes in rats fed with HCD com-
pared to control group (Figure 1A & B). Interestingly,
administration of rutin in combination with HCD resulted
in a significant increase the expression of these genes by
245% and 441% compared to HCD group and by 166%
and 90% compared to control group respectively.Table 2 Effect of High cholesterol diet, rutin and their combin
Group AST (U/L) ALT (U/L) Triglycerides (m
Control (rat chow) 35.64±1.52 22.76±0.84 63.03±5.9
Rutin (0.2%) 34.40±0.79 20.43±0.33 56.33±6.1
High cholesterol diet 53.30±3.07* 35.71±1.87* 93.30±4.94
Rutin (0.2%) + HCD 37.60±2.00# 23.10±1.25# 86.46±5.25
Data were expressed as Mean±SEM. *&# indicate a significant change from control
a post ANOVA test. Six animals were used in each group.The expression of Glutathione S transferase α, para-
oxonase-1, sulfiredoxin and glutamate-cystein ligase were
significantly increased by 220%, 160%, 250% and 230% re-
spectively, in HCD fed rats compared to the control
group (Figures 2A, B, C & D). The rutin supplementation
with HCD resulted in significant decrease in the ex-
pression of Glutathione S transferase α, PON-1 and
sulfiredoxin genes by 63% 130% and 54% respectively and
an insignificant decrease in the glutamate-cystein ligase
gene expression by 45% as compared with HCD group.
Discussion
Obesity is a risk factor for many diseases such as car-
diovascular [46] and liver diseases [3,4]. Rat models fed
with HCD can be used as model of the human obesity
syndrome [47,48]. The present study examined the
hepatoprotective effect of rutin against hepatotoxicity
induced by HCD in rat model and demonstrated that
HCD caused hepatotoxicity through increasing plasma
levels of liver enzymes ALT and AST. In agreement
with earlier studies, the elevated ALT and AST levels
are attributed to hepatic damage that may contribute
to oxidative stress unbalance [49,50]. Rutin has re-
duced the oxidative stress in liver, kidney, and brain
tissues of rats [51,52]. As a result of rutin supplemen-
tation, ALT and AST levels were lowered that led to
decrease the hepatic damage caused by HCD feeding.
The present results showed that rutin can protect
hepatocyte against toxicity induced by HCD.ation on plasma levels of AST, ALT, TG, TC, HDL and LDL
g/dl) Total cholesterol (mg/dl) HDL (mg/dl) LDL (mg/dl)
9 66.67±4.25 29.91±1.32 48.32±2.32
2 61.70±3.57 30.93±0.98 47.09±1.87
* 125.33±13.94* 24.87±1.54* 80.72±3.19*
* 98.06±7.06*# 26.86±1.35 71.50±2.93*#
and HCD, respectively, at p < 0.05 using ANOVA followed by Tukey-Kramer as
Table 3 Effect of High cholesterol diet, rutin and their
combination on levels of MDA, GSH and H2O2
Group MDA (mmol/g) GSH (nmol/100mg) H2O2 (μM)
Control (rat chow) 256±7.21 171.91±7.48 1.3±0.6




Rutin (0.2%) + HCD 263.56±9.02*# 192.87±4.22*# 1.8±0.98#
Data were expressed as Mean±SEM. *&# indicate a significant change from
control and HCD, respectively, at p < 0.05 using ANOVA followed by Tukey-
Kramer as a post ANOVA test. Six animals were used in each group.
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and increases fibroblastic activity, leading to liver cirrho-
sis and carcinoma. Previous study has demonstrated that
rutin has a protective effect against HCD-induced liver
cirrhosis [50]. Lipid alterations have been considered as














































































Figure 1 Showing the Effect of HCD, rutin, and their combination
on the expression levels of Glutathione peroxidase (A) and
Glutathione reductase (B) in rat liver. Data were presented as
mean ± SEM (n = 6). * and # indicate significant change from control
and HCD, respectively, at P < 0.05 using ANOVA followed by Tukey–
Kramer as a post ANOVA test.of increased in the production of ROS as well as reduced
antioxidant enzymes [53,54]. Reactive oxygen species and
lipid peroxidation products impaired the respiratory chain
in hepatocytes through oxidative damage to the mitochon-
drial DNA. In the present study, HCD feeding resulted in
increasing the levels of TG, TC and LDL and decreasing in
HDL as compared with control group; our finding was in
agreement with other studies [55,56].
High cholesterol diet leads to dyslipidemic syndrome
and hyperlipidemia that characterized by increasing in
TG and decreased in HDL-Cholesterol. [57]. Dyslipidemic
syndrome produced anti-inflammatory effects by inhibiting
the expressions of proinflammatory cytokines [58,59]. In
the present study, rutin-supplement attenuated HCD-
induced hepatotoxicity by lowering the concentrations of
TC, TG and LDL. Similarly, rutin lowers the lipid compo-
nents in the serum of hyper-cholesterolemic rats, probably
by reducing the activity of 3-hydroxy-3-methyl-glutaryl-
CoA reductase [60]. This may be explained on the basis
that rutin has a strong ability to chelate multivalent metal
ions, especially zinc, calcium and iron [39].
Lipid peroxidation is characterized by imbalance be-
tween oxidant-antioxidant and ROS are thought to be a
component of obesity-induced pathology [61,62]. The
data of this study showed that HCD increased lipid per-
oxidation in hepatic tissue as expressed by increased
tissue levels of MDA, this will cause an increased accu-
mulation of H2O2 which could further stimulate lipid
peroxidation. The present results were convenient with
earlier studies [62,63] showed that obesity is an inde-
pendent risk factor for increasing lipid peroxidation and
decreased activity of cytoprotective enzymes. Damage,
at the cellular level by oxidative stress, is attenuated
by antioxidant enzyme such as PON-1, GSHPx, GPx,
GR and Glutathione S transferase α, sulfiredoxin and
glutamate-cystein ligase. When the balance between
ROS production and antioxidant defense is lost oxida-
tive stress occurred through a serious of events deregu-
lates the cellular functions leading various pathological
conditions [26].
The GSH antioxidant system plays critical role in the
detoxification process of liver and is involved in over-
coming various hepatotoxins-induced liver injuries [64].
The increasing GSH levels can protect cells against oxi-
dative damage, while depleting cellular GSH can pro-
mote such injury [65,66]. Our results showed that GSH
level was decreased in HCD fed rats compared to control
which was in agreement with other [67]. The cellular roles
of GR have been broadened in various physiological phe-
nomena, especially cellular response against many kinds of
stresses by reducing glutathione disulfide (GSSG) to the
sulfhydryl form GSH which is an important cellular anti-
oxidant [68]. Glutathione peroxidase is a selenoenzyme,

































































































































































Figure 2 Showing the Effect of HCD, rutin, and their combination
on the expression levels of Glutathione S transferase α (A),
paraoxonase-1 (B), sulfiredoxin (C) and glutamate-cystein
ligase (D) in rat liver tissues. Data were presented as mean ± SEM
(n = 6). * and # indicate significant change from control and HCD,
respectively, at P < 0.05 using ANOVA followed by Tukey–Kramer as a
post ANOVA test.
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of GR results in cellular GSSG content increase, and
reduction of GSH/GSSG ratio is involved in many re-
sponses against oxidative stress. Our results showed
decrease in GR and GPx genes expression in liver tis-
sues of HCD fed rats and were in agreement with
others [70,71]. Rutin supplementation led to increase
the expression of these genes in liver tissues. These
data showed that HCD not only increase the free rad-
ical formation but also decrease its ability to detoxify
ROS, which lead to hepatocellular damage [72].
Paraoxonase-1 (PON-1), an enzyme with lactonase
and esterase activities, is synthesized mainly by the liver
[73,74] and it plays a role in the regulation of oxidative
stress, fibrosis and hepatic cell apoptosis in chronic liver
diseases. [75]. The present results showed that the HCD
feeding significantly overexpressed the expression of
PON-1 in liver tissues. This increase in the expression en-
hanced the sensitivity to liver damage development. The
increasing in PON-1 hepatic expression in chronic hepa-
titis and liver cirrhosis, probably as a response to the en-
hanced oxidative stress observed in the earliest stages of
these diseases [75]. Our results were disagreement with
Zhang et al., who proposed that PON-1 over expression
provides strong protection against the development of ex-
perimental liver disease [76]. Rutin supplementation led to
decrease the expression of PON-1 gene in liver tissues,
and this attributed to its effect as an antioxidant and re-
duced oxidative stress in plasma, liver and other organs
[51,77]. The present finding was in agreement with re-
cent study who found that rutin administered to High
fat diet fed rats attenuated the diet-induced metabolic
syndrome, NASH, and cardiovascular abnormalities [78].
Glutamate-cysteine ligase catalyzes the biosynthesis of
cellular GSH and is considered one of antioxidant system
for counteracting ROS produced during oxidative stress
injury. Sulfiredoxin-1 (Srx1), an antioxidant, contains a
C-terminal cysteine residue that is highly conserved and
crucial for its antioxidant function [79,80]. It plays a key
role in cellular responses to oxidative stress by restoring
the activity of over-oxidized peroxiredoxins [80,81]. The re-
sults of the present study show that Srx1, GCL and GSTα
expressions are selectively up-regulated in liver tissues of
rat fed with HCD. Reactive oxygen species elicit many
different responses depending upon the severity of the
damage and the duration of the exposure [82].
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(JNK) transiently thereby promoting cell proliferation.
However, persistent JNK activation due to severe oxida-
tive stress ultimately causes cell death via activation of
pro-apoptotic signaling pathway [83,84]. In the current
study the activation of GSTα was due to the modula-
tions of GST levels on JNK activation by formation of
GSTα-JNK complex integrity in sequence to inhibit its
activation. Our results was in agreement with other
studies [85,86], who shows that, besides detoxification of
GST-α, it plays an important role in signaling events by
modulating stress cell signaling kinases in particular
through inhibition of JNK activation. The upregulation
of GCL in our data was in agreement with Nishiya et al.,
who found that, marked upregulation of GCL gene in
rats treated with tienilic acid induced hepatotoxicity
[87]. Similarly, Wu and his colleague found that Cd-
induced oxidative stress increased the mRNA expression
of GCL with graded Nrf2 activation. [88]. However, the
present data is disagreement with Wang and his col-
leagues; they found that the downregulation of GCL is
confirmed the damage of liver cells in mice treated with
Dioscorea bulbifera rhizome [89]. The up-regulation of
Sxr1 to maintains the balance between H2O2 produc-
tion and elimination and then protects liver cells from
apoptosis; our finding was in agreement with previous
study [90]. In the present study rutin administration re-
versed the changes induced by HCD feeding in rats to
normal levels probably by reducing oxidative stress and
inflammation in liver tissue.
Conclusion
The high-cholesterol diet induces symptoms of metabolic
syndrome in rat including hepatotoxicity with alteration in
the oxidative stress markers. Rutin reversed the changes in-
duced by HCD probably by reducing the oxidative stress
and inflammation in the liver. Therefore the administration
of rutin may be used as an antioxidant in decreasing the
hepatic stress in humans as a treatment.
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